ACADIA Pharmaceuticals
ACAD
#3223
Rank
NZ$7.83 B
Marketcap
NZ$46.33
Share price
-2.48%
Change (1 day)
44.20%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$94.89 Million

According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is NZ$94.89 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$92.19 M1.92%
2023-12-31NZ$90.45 M-7.37%
2022-12-31NZ$97.65 M3.53%
2021-12-31NZ$94.32 M37.37%
2020-12-31NZ$68.66 M372.15%
2019-12-31NZ$14.54 M
2018-12-31N/A
2011-12-31NZ$0.04 M-71.24%
2010-12-31NZ$0.14 M-77.63%
2009-12-31NZ$0.63 M-69.8%
2008-12-31NZ$2.11 M-24.23%
2007-12-31NZ$2.78 M-17.36%
2006-12-31NZ$3.37 M29.3%
2005-12-31NZ$2.6 M-26.47%
2004-12-31NZ$3.54 M-52.64%
2003-12-31NZ$7.48 M-39.11%
2002-12-31NZ$12.29 M285.87%
2001-12-31NZ$3.18 M-75.61%
2000-12-31NZ$13.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Vanda Pharmaceuticals
VNDA
NZ$18.89 M-80.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.35 B 110,918.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$73.59 B 77,454.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.28 B 83,453.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.37 B 93,025.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA